What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Samuel M. Cohen mainly focuses on Carcinogen, Urinary bladder, Pathology, Internal medicine and Hyperplasia.
The concepts of his Carcinogen study are interwoven with issues in Cancer research, Bioassay and Toxicity, Genotoxicity.
Samuel M. Cohen interconnects Carcinogenesis, Cancer, Growth factor and Immunology in the investigation of issues within Cancer research.
His studies in Urinary bladder integrate themes in fields like Bladder cancer, Urine and Kidney.
The study incorporates disciplines such as Rat Urinary Bladder and Cytotoxicity in addition to Pathology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology.
His most cited work include:
- Cell proliferation in carcinogenesis (905 citations)
- Genetic errors, cell proliferation, and carcinogenesis (424 citations)
- A framework for human relevance analysis of information on carcinogenic modes of action. (352 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Carcinogen, Endocrinology, Urinary bladder and Pathology are his primary areas of study.
His study in Urinary system, Toxicity and Bladder cancer is carried out as part of his studies in Internal medicine.
His research integrates issues of Carcinogenesis, Cancer research, Pharmacology and Cell growth in his study of Carcinogen.
His Carcinogenesis research includes themes of Molecular biology and Mode of action.
His Cancer research research integrates issues from Cancer, Immunology and Cytotoxicity.
His study focuses on the intersection of Urinary bladder and fields such as Hyperplasia with connections in the field of Epithelium.
He most often published in these fields:
- Internal medicine (27.75%)
- Carcinogen (27.52%)
- Endocrinology (23.62%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (13.30%)
- Carcinogen (27.52%)
- Pharmacology (11.24%)
In recent papers he was focusing on the following fields of study:
Samuel M. Cohen focuses on Cancer research, Carcinogen, Pharmacology, Carcinogenesis and Cancer.
His Cancer research study also includes
- Breast cancer, which have a strong connection to Drug delivery,
- Cytotoxicity which intersects with area such as Programmed cell death.
His research in Carcinogen intersects with topics in Mode of action, Acetaminophen and Bioinformatics.
His Pharmacology study integrates concerns from other disciplines, such as Hyperplasia and Cell growth.
His Cancer research incorporates themes from Risk assessment, Bioassay and Genotoxicity.
He focuses mostly in the field of Bioassay, narrowing it down to matters related to Urinary system and, in some cases, Pathology.
Between 2015 and 2021, his most popular works were:
- Inorganic arsenic: A non-genotoxic carcinogen. (50 citations)
- Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society (45 citations)
- Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary areas of investigation include Carcinogen, Pharmacology, Carcinogenesis, Mode of action and Cancer.
With his scientific publications, his incorporates both Carcinogen and Context.
His Carcinogenesis study is related to the wider topic of Biochemistry.
His research in Mode of action focuses on subjects like Bioassay, which are connected to Human cell, Human cancer and Bioinformatics.
His research in Cancer intersects with topics in Cell, Cellular receptor, Cancer research and Neuroscience.
He interconnects Lung, Hyperplasia and Adenoma in the investigation of issues within Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
